Locating Atrial Fibrillation Rotor and Focal Sources Using Iterative Navigation of Multipole Diagnostic Catheters
ConclusionsThe algorithm could play a critical role in clinical electrophysiology laboratories for mapping patient-specific ablation of AF sources located outside the pulmonary veins and improving the procedure success.
CONCLUSIONS: To our knowledge, this is the first report of association of the CACNA1C, CTNNA3, PKP2, ANK2 and SCN10A genes with FAF; it is also the first study in Russian families. PMID: 31539150 [PubMed - in process]
Conditions: Atrial Fibrillation; Atrial Flutter; Stroke; Cardiac; Heart Failure; Arrhythmia Interventions: Behavioral: SDMT; Behavioral: Usual Care Sponsors: Stanford University; American Heart Association; Boston University; East Carolina University; Ochsner Health System; The Cleveland Clinic Not yet recruiting
ConclusionsArrhythmias, including clinically significant abnormal rhythms, were common. Tachyarrhythmias were more frequent during dialysis and the immediate postdialytic period. The relevance of these findings to clinical outcomes requires additional study.
CONCLUSIONS: Increasing age, male gender and pre-existing AF independently predicted permanent AF development. Occurrence of permanent AF was significantly associated with reduced survival. PMID: 31527561 [PubMed - as supplied by publisher]
BioSig Technologies and Mayo Clinic have joined forces once again, this time to develop a new product pipeline to support some of the more advanced features of BioSig's Pure EP System. SamuelÂ Asirvatham, MD, Mayo Clinic's vice-chair of innovation and medical director of the electrophysiology (EP) laboratory, will lead the new development program.Â The company previously signed a 10-year collaboration agreement with Mayo Clinic in March 2017. "The new product that we intend to develop under the latest licensing will seek to significantly advance the current arrhythmia treatments," said Kenne...
ConclusionThere has been a significant increase in primary prevention practices for AF and this is reflected in the number of stroke patients presenting with known AF on a NOAC, however more needs to be done as there are still patients who have AF that are not being anticoagulated in the community.
Sensors, Vol. 19, Pages 3969: Enabling Heart Self-Monitoring for All and for AAL—Portable Device within a Complete Telemedicine System Sensors doi: 10.3390/s19183969 Authors: Andrés-Lorenzo Bleda Francisco-Manuel Melgarejo-Meseguer Francisco-Javier Gimeno-Blanes Arcadi García-Alberola José Luis Rojo-Álvarez Javier Corral Ricardo Ruiz Rafael Maestre-Ferriz During the last decades there has been a rapidly growing elderly population and the number of patients with chronic heart-related diseases has exploded. Many of them (such as those with congestive heart failure or so...
ConclusionThe overall estimated incidence of AF and recurrent AF during pregnancy is as high as 2.2% and 39.2%, respectively. AF during pregnancy may result in poor maternal and fetal outcomes.
This article is protected by copyright. All rights reserved.
CONCLUSION: The overall estimated incidence of AF and recurrent AF during pregnancy is as high as 2.2% and 39.2%, respectively. AF during pregnancy may result in poor maternal and fetal outcomes. PMID: 31521944 [PubMed - as supplied by publisher]